DHR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DHR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Danaher's Average Total Inventories for the three months ended in Mar. 2024 was $2,620 Mil. Danaher's Cost of Goods Sold for the three months ended in Mar. 2024 was $2,309 Mil. Hence, Danaher's Days Inventory for the three months ended in Mar. 2024 was 103.52.
The historical rank and industry rank for Danaher's Days Inventory or its related term are showing as below:
During the past 13 years, Danaher's highest Days Inventory was 115.55. The lowest was 72.93. And the median was 92.59.
Danaher's Days Inventory declined from Mar. 2023 (122.65) to Mar. 2024 (103.52).
Inventory Turnover measures how fast the company turns over its inventory within a year. Danaher's Inventory Turnover for the three months ended in Mar. 2024 was 0.88.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Danaher's Inventory-to-Revenue for the three months ended in Mar. 2024 was 0.45.
The historical data trend for Danaher's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Danaher Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 75.04 | 72.93 | 96.55 | 96.57 | 99.23 |
Danaher Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Days Inventory | Get a 7-Day Free Trial | 122.65 | 96.14 | 98.57 | 239.55 | 103.52 |
For the Diagnostics & Research subindustry, Danaher's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Days Inventory distribution charts can be found below:
* The bar in red indicates where Danaher's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Danaher's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (2765 | + | 2594) | / | 2 ) | / | 9856 | * | 365 |
= | 2679.5 | / | 9856 | * | 365 | ||||
= | 99.23 |
Danaher's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:
Days Inventory (Q: Mar. 2024 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Dec. 2023 ) | + | Total Inventories (Q: Mar. 2024 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2024 ) | * | Days in Period |
= | ( (2594 | + | 2645) | / | 2 ) | / | 2309 | * | 365 / 4 |
= | 2619.5 | / | 2309 | * | 365 / 4 | ||||
= | 103.52 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Danaher (NYSE:DHR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Danaher's Inventory Turnover for the three months ended in Mar. 2024 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 2309 | / | 2619.5 | |
= | 0.88 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Danaher's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 2619.5 | / | 5796 | |
= | 0.45 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Danaher's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Jose-carlos Gutierrez-ramos | officer: SVP, Chief Scientific Officer | C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142 |
Linda Filler | director | 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON DC 20037 |
Daniel Raskas | officer: VP-Corporate Development | 2099 PENNSYLVANIA AVENUE, NORTHWEST, WASHINGTON DC 20006 |
Teri List | director | 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037 |
Joakim Weidemanis | officer: Executive Vice President | 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037 |
Walter G Lohr | director | DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006 |
Georgeann Couchara | officer: SVP, Human Resources | 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037 |
Raymond C Stevens | director | 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037 |
Matthew Mcgrew | officer: EVP & Chief Financial Officer | 2200 PENNSYLVANIA AVENUE, NW, SUITE 800 W, WASHINGTON DC 20010 |
Jennifer Honeycutt | officer: Executive Vice President | 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037 |
Alan G Spoon | director | 1150 15TH ST NW, WASHINGTON DC 20071 |
Rainer Blair | officer: Executive Vice President | 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037 |
Feroz Dewan | director | C/O ARENA HOLDINGS MANAGEMENT LLC, 119 FIFTH AVENUE - 8TH FLOOR, NEW YORK NY 10003 |
Mitchell P Rales | director, officer: Chairman of Exec. Committee | 11790 GLEN ROAD, POTOMAC MD 20854 |
Brian W Ellis | officer: Senior Vice President - GC | 2200 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20037 |
From GuruFocus
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
By GuruFocus Research • 01-22-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.